Snowden Capital Advisors LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1903055
New York, NY
Position in VRTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,711,587
-$64,677 QoQ
Shares Held
3,833
-2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Snowden Capital Advisors LLC holds $12,608,129 across 22 Biotechnology names. VRTX ranks #2 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,864 | $2,212,840 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
3,833 | $1,711,587 | |
| 3 | ARGX |
Argenx SE
|
2,117 | $1,545,939 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,383 | $1,247,429 | |
| 5 | INSM |
INSMED Inc
|
7,571 | $1,238,009 | |
| 6 | MRNA |
Moderna, Inc.
|
12,722 | $646,277 | |
| 7 | IDYA |
IDEAYA Biosciences, Inc.
|
19,231 | $640,776 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
1,197 | $355,473 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,711,587 | 3,833 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,776,264 | 3,918 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,500,372 | 3,831 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,761,656 | 3,957 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,228,717 | 4,597 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,908,798 | 4,740 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,295,865 | 11,387 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,558,798 | 13,993 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,997,189 | 14,347 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,735,928 | 14,097 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,714,658 | 13,558 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,800,756 | 13,642 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,183,499 | 13,278 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,854,346 | 13,347 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,393,266 | 4,812 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,446,991 | 5,135 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,028,743 | 3,942 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $81,032 | 369 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $704,518 | 3,884 | Shares | Sole | 2024-02-06 | |
| 2021-06-30 | $339,141 | 1,682 | Shares | Sole | 2024-01-08 | |
| 2021-03-31 | $246,908 | 1,149 | Shares | Sole | 2024-01-08 | |
| 2020-12-31 | $223,813 | 947 | Shares | Sole | 2024-01-08 | |
| 2020-09-30 | $231,029 | 849 | Shares | Sole | 2024-01-08 | |
| 2020-06-30 | $245,892 | 847 | Shares | Sole | 2024-01-08 | |
| 2020-03-31 | $207,254 | 871 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||